# Relmada Therapeutics, Inc.: Form 8-K, filed Jul 23, 2025

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: 8-K
- Filed: 2025-07-23
- Accepted by EDGAR: Jul 23, 2025, 16:30 ET
- Period: 2025-07-22
- Accession: 0001213900-25-066995
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000121390025066995/ea0249919-8k_relmada.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000121390025066995/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000121390025066995/ea0249919-8k_relmada.htm

Filed Jul 23, 2025.
Source: SEC EDGAR, the filing index for accession 0001213900-25-066995. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
